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Abstract
Tankyrases are poly(ADP-ribose)polymerases (PARPs) which recognize their substrates via their ankyrin repeat cluster 
(ARC) domains. The human tankyrases (TNKS/TNKS2) contain five ARCs in their extensive N-terminal region; of these, 
four bind peptides present within tankyrase interactors and substrates. These short, linear segments, known as tankyrase-
binding motifs (TBMs), contain some highly conserved features: an arginine at position 1, which occupies a predominantly 
acidic binding site, and a glycine at position 6 that is sandwiched between two aromatic side chains on the surface of the 
ARC domain. Tankyrases are involved in a multitude of biological functions, amongst them Wnt/β-catenin signaling, the 
maintenance of telomeres, glucose metabolism, spindle formation, the DNA damage response and Hippo signaling. As 
many of these are relevant to human disease, tankyrase is an important target candidate for drug development. With the 
emergence of non-catalytic (scaffolding) functions of tankyrase, it seems attractive to interfere with ARC function rather 
than the enzymatic activity of tankyrase. To study the mechanism of ARC-dependent recruitment of tankyrase binders and 
enable protein-observed NMR screening methods, we have as the first step obtained a full backbone and partial side chain 
assignment of TNKS2 ARC4. The assignment highlights some of the unusual structural features of the ARC domain.
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Biological context
The tankyrases (TNKS/ARTD5, TNKS2/ARTD6) are 
poly(ADP-ribose)polymerases (PARPs) and as such cata-
lyse the processive modification of protein substrates with 
poly(ADP-ribose) (PAR) chains, thereby consuming their 
co-substrate  NAD+ (Haikarainen et al. 2014). PARPs are 
part of a larger family of Diphtheria-toxin-like ADP-ribosyl-
transferases (ARTDs), which share variants of a conserved 
catalytic domain that either modifies substrates with mono-
ADP-ribose or PAR, or lacks detectable catalytic activity 
(Hottiger et al. 2010; Vyas et al. 2014). Different ARTD 
family members are distinguished by unique combinations 
of accessory domains, which confer functional diversity 
(Hottiger et al. 2010). In the case of the tankyrases, these 
are an extensive N-terminal region comprising five consecu-
tive ankyrin repeat clusters (ARCs), either flexibly or rigidly 
linked, and responsible for substrate recruitment (Seimiya 
et al. 2004; Guettler et al. 2011; Eisemann et al. 2016). The 
ARCs are followed by a polymerizing sterile alpha motif 
(SAM) domain (De Rycker and Price 2004; Mariotti et al. 
2016; Riccio et al. 2016) that precedes the PARP domain 
(Lehtiö et al. 2008). ARCs and the SAM domain direct 
tankyrase to regulators of a wide range of biological pro-
cesses, among which Wnt/β-catenin signaling (Huang et al. 
2009; Mariotti et al. 2016, 2017; Yang et al. 2016), the main-
tenance and mitotic resolution of telomeres (Smith et al. 
1998; Smith and de Lange 2000; Dynek and Smith 2004) 
and glucose metabolism (Chi and Lodish 2000; Yeh et al. 
2007; Zhong et al. 2016) are some of the best-studied. Addi-
tional roles of tankyrase include the regulation of mitotic 
spindle formation (Chang et al. 2005, 2009), Hippo signal-
ing (Wang et al. 2015; Troilo et al. 2016; Jia et al. 2017) 
and emerging functions in the DNA damage response (Nagy 
et al. 2016), cell migration (Lupo et al. 2016), and Notch 
signaling (Bhardwaj et al. 2017), to name a few. Proteomics 
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studies and in-silico predictions of tankyrase binders illus-
trate the diverse cellular functions of tankyrase (Guettler 
et al. 2011; Li et al. 2017; Bhardwaj et al. 2017).
Of the five ARCs, four (ARCs 1, 2, 4 and 5) are known to 
bind substrates featuring a degenerate six- to eight-amino-
acid peptide motif known as the tankyrase-binding motif 
(TBM); ARC3 shows no detectable substrate binding (Sbo-
dio and Chi 2002; Seimiya et al. 2004; Guettler et al. 2011). 
Studies reported in 2011 and 2012 first revealed the struc-
tural basis of substrate recruitment by tankyrase (Guettler 
et al. 2011; Morrone et al. 2012). To date, numerous addi-
tional crystal structures of tankyrase ARCs from both TNKS 
and TNKS2, typically complexed with TBM peptides, are 
available (Li et al. 2016; Eisemann et al. 2016; Xu et al. 
2017a, b; DaRosa et al. 2018).
The TBM binding site in substrate-binding ARCs is 
highly conserved (Guettler et al. 2011). It features a sub-
pocket, the so-called ‘arginine cradle’, that engages an essen-
tial arginine residue at TBM position 1. A second key bind-
ing determinant is a channel lined by two aromatic amino 
acids which accommodates an essential glycine residue at 
TBM position 6, forming an ‘aromatic glycine sandwich’ 
(Guettler et al. 2011). Their strict requirement suggests that 
the arginine and glycine residues represent critical dock-
ing points in substrate recruitment. Additional contacts 
are provided by residues at TBM positions 4 and 5, which 
interact with a ‘central patch’ in the peptide-binding pocket, 
and at TBM position 8, where an acidic residue can confer 
increased binding affinity through a salt bridge (Guettler 
et al. 2011). The eight amino acids of the TBM do not need 
to be contiguous: the essential arginine can be N-terminally 
displaced to varying extent, and structural plasticity or 
looping of such TBM peptides enables both the arginine 
and a hydrophobic side chain at position 4 to dock as in 
“canonical” TBM peptides (Morrone et al. 2012; DaRosa 
et al. 2018). Moreover, there is evidence for tankyrase tar-
gets devoid of detectable TBM sequences (Li et al. 2017; 
Bhardwaj et al. 2017). These binders may either indirectly 
interact with tankyrase or be recruited through direct bind-
ing by alternative, hitherto unknown binding mechanisms.
Tankyrases are being explored as potential therapeutic 
targets in conditions such as cancer, neurodegeneration, 
fibrosis and diabetes (Riffell et al. 2012; Haikarainen et al. 
2014; Zhong et al. 2016; Mariotti et al. 2017). These efforts 
led to the development of a wide range of tankyrase catalytic 
inhibitors (Haikarainen et al. 2014; Mariotti et al. 2017). 
The response of tankyrase to catalytic inhibition, however, 
is complex. It not only leads to the loss of tankyrase’s enzy-
matic PARP activity but typically also to tankyrase accumu-
lation and that of many of its substrates (Huang et al. 2009; 
Zhang et al. 2011; Bhardwaj et al. 2017) and potentially to 
increased tankyrase polymerization (De Rycker and Price 
2004). The accumulation of tankyrase and its substrates 
upon tankyrase catalytic inhibition is a consequence of an 
attenuated PAR-dependent ubiquitination pathway (Zhang 
et al. 2011; DaRosa et al. 2015). Moreover, some activi-
ties of tankyrase may be mediated by non-catalytic (scaf-
folding) mechanisms: at least elevated tankyrase levels can 
drive Wnt/β-catenin signalling independently of PARylation, 
requiring only the substrate-binding ARCs and the polym-
erizing SAM domain (Mariotti et al. 2016). Consequently, 
targeting tankyrase’s accessory domains provides an attrac-
tive alternative means to inhibit tankyrase function. This 
approach would block both tankyrase-dependent scaffold-
ing and substrate PARylation. As proof of concept, a recent 
study demonstrates that an affinity-optimised TBM (Guet-
tler et al. 2011), when stabilised by cyclisation and fused to 
a facilitator of cell permeability, can inhibit Wnt/β-catenin 
signalling in cells (Xu et al. 2017b).
Here, we report the assignment of ARC4 of human 
TNKS2, which will enable a more elaborate characterisa-
tion of substrate recruitment by tankyrase ARCs and the 
development of substrate binding antagonists.
Methods and experiments
The expression construct for TNKS2 ARC4 (NM_025235), 
comprising residues 488–649 cloned into vector pETM-30, 
was described previously (Guettler et al. 2011). To produce 
15N-labelled or 15N–13C-labelled protein, E. coli (BL21-
CodonPlus(DE3)-RIL) cells were grown in M9 minimal 
media (Laboratory Support Services, ICR) supplemented 
with 15NH4Cl or 15NH4Cl (at 1 g/L M9) and 13C d-glucose 
(Cambridge Isotope Laboratories) (at 6 g/L M9), respec-
tively, following the protocol of Marley and colleagues 
(Marley et al. 2001). Briefly, freshly transformed bacteria 
were grown at 37 °C in 4 L of standard LB media (Labora-
tory Support Services, ICR) containing kanamycin (50 µg/
mL) and chloramphenicol (34 µg/mL) until they reached an 
 OD600 of 0.7. At this point, cells were transferred into M9 
minimal media containing appropriate isotope(s) by collect-
ing cells by centrifugation and resuspending them in 1 L 
of the final M9 minimal media. The culture was incubated 
at 37 °C for 1 h to allow the cells to recover, and protein 
expression was induced by addition of 0.5 mM IPTG. Pro-
tein expression was carried out at 18 °C for 16 h. Cells were 
next harvested by centrifugation, and the pellet was stored at 
− 80 °C until purification following the previously described 
method (Guettler et al. 2011; Pollock et al. 2017).
NMR samples were prepared in a buffer of 20  mM 
sodium phosphate pH 7.0, 100 mM sodium chloride and 
1 mM TCEP with a protein concentration of 1 mM. Back-
bone and partial sidechain assignments of the domain 
were obtained from a combination of 3D HNCACB, (H)
C(CCO)NH, HNCO, HN(CA)CO and 15N resolved 3D 
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NOESY-HSQC experiments recorded at 700 and 800 MHz 
on Bruker Avance spectrometers at 20 °C. Spectra were pro-
cessed with Topspin 3.1 (Bruker), and all assignments were 
performed with CCPN analysis 2.4 (Vranken et al. 2005).
Assignments and data deposition
The TNKS2 ARC4 domain construct comprises 165 amino 
acids (residues 488–649 plus 3 additional N-terminal amino 
acids, GAM, resulting from the cloning method) and despite 
its substantial molecular weight of 17.8 kDa gives excellent 
NMR spectra (see Fig. 1). It was possible to find assignments 
for 164 residues with only the N-terminal glycine missing 
completely. Of the assigned residues, backbone amide peaks 
were missing for only two of the non-proline residues (R525 
and V584). Out of a total of 165 backbone nitrogens, 165 α 
carbons, 151 β carbons, 140 γ carbons, 99 δ carbons, 31 ε 
carbons and 165 backbone carbonyls, a total of 156 (94.5%), 
163 (98.7%), 148 (98.0%), 68 (48.6%), 42 (42.4%) and 11 
(35.4%), respectively, could be assigned. The assignment 
has been deposited with the BMRB, accession code 27747.
Comparison to X‑ray structure
The NMR spectra of ARC4 contain a number of unusual 
features, most prominently the appearance of 3 peaks for 
histidine sidechain Nε2/Hε2 groups, two of which could be 
assigned. Such resonances are usually exchange-broadened 
beyond detection. ARC4, however, makes a rather unusual 
use of histidines as part of the conserved ankyrin repeat 
(AR) infrastructure, with regular occurrences at the N-ter-
minal end of the first helix and the C-terminal end of the 
second helix of each AR. Thus, they appear on opposite 
sides of the protein in the central three ARs (see Fig. 2). 
Those at the C-termini of the second helix point into solu-
tion whereas those at the N-termini of the first are covered 
by the long loop/beta hairpins which connect adjacent ARs. 
The latter are part of a highly conserved TPLH sequence 
motif (Mosavi et al. 2002). As part of this motif, the histi-
dine Hε2 acts as an H-bond donor to the backbone carbonyl 
group of the residue preceding the TPLH motif in the fol-
lowing repeat (Preimesberger et al. 2015). Our observation 
of three histidine sidechain Nε2/Hε2 groups is therefore 
in good agreement with the structure. Curiously, the  Cα 
secondary shifts of two of these three protected histidines 
(H531 with almost 9 ppm, H564 with almost 10 ppm; H597 
A
B
Fig. 1  1H-15N HSQC spectrum of 1 mM uniformly 15N/13C labelled 
ARC4 recorded at a temperature of 293 K and a field of 700 MHz. 
Note that the sidechain resonances of histidines and arginines are 
folded from their original position in the 15N dimension. a Overview 
spectrum. b Majority of the backbone resonances in the spectrum 
(indicated by box in a). Well resolved peaks have been labelled with 
their assignments; pairs of peaks for sidechain  NH2 groups are con-
nected by red lines
Fig. 2  Structure of ARC4 (PDB code 3TWQ) showing all histidine 
side chains as sticks in pink while the main backbone is shown in car-
toon style coloured by sequence from N-terminus (blue, left) to C-ter-
minus (red, right). Ankyrin repeats (ARs) are numbered AR1 to AR5. 
The positions of the histidines occupying key positions in the three 
central ARs are clearly visible with H548, H581 and H614 pointing 
towards the solvent (top) while H531, H564 and H597 (bottom) are 
covered by the β-hairpins linking ARs. H553 (front) and H571 (back, 
not labelled) are not part of the conserved AR pattern and exposed to 
solvent
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with 5.5 ppm is less extreme but still substantial) are well 
outside the [− 5.0, + 5.0] bracket of all the other residues 
(see Fig. 2). This pattern is less apparent for the  Cβ and 
C’ secondary shifts. However, it is repeated, albeit with a 
shift of − 3 in the sequence, for the  Hα secondary chemical 







Fig. 3  Secondary chemical shifts (Wishart and Sykes 1994) and 
backbone dihedral angles predicted from Dangle and extracted from 
the crystal structure of ARC4 (PDB code 3TWQ) (Guettler et  al. 
2011) All values were calculated using CCPN analysis version 2.4, 
and figures were generated in Apple Numbers, inkscape and keynote. 
a Cα, b Cβ, c C’, d Hα, e phi, f psi. Dihedral angles from Dangle 
are shown in red, those from the crystal structure in blue. Positions 
of secondary structure elements based on the chemical shift analysis 
are indicated as grey bars. Positions of the protected histidines with 
chemical shift outliers are indicated by red stars
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+ 1.4, much larger than all the other values, which are well 
within the [− 0.8, + 0.8 ppm] bracket. It is not completely 
clear what causes the unusual chemical shifts. The fact that 
these instances of unusual secondary chemical shifts occur 
in precisely repeated structural units in AR–AR boundaries 
suggests that the most unusual backbone conformation, in 
combination with the hydrogen bonds from the histidine 
side chains to the backbone amides i-3 (Preimesberger et al. 
2015), are likely to be the causative factor.
Another unusual feature is the sidechain amide group of 
N622, which has proton resonances at 8.33 and 3.59 ppm. 
The extreme shift of one of the amides can be explained by 
its position extremely close to the aromatic ring of F593, 
with which it is very likely to form a π–hydrogen bond.
Finally, we can observe three arginine sidechain Nε, 
which is also not common at pH values around 7. Two 
of these could be assigned to R538 and R494. R494 is 
very likely involved in simultaneous salt bridges with the 
neighbouring E491 and E523 (shortest distances from 
R494Hη11–E491 Oε2: 2.0 Å; R494Hε–E523 Oε2: 3.0 Å). 
The Hε of R538 is likely to make a hydrogen bond to the 
backbone carbonyl oxygen of K501 (distance R538 Hε-K501 
O’: 2.0 Å).
Secondary structure
We analysed the secondary structure of ARC4, based on 
the backbone chemical shifts, and compared it to the crystal 
structure (Guettler et al. 2011) (PDB code 3TWQ). In the 
first instance, we qualitatively compared the positions of 
the helices; we next quantitatively compared the backbone 
dihedral angles predicted by Dangle (Cheung et al. 2010) to 
those extracted from the crystal structure (see Fig. 3). The 
positions of the helices are generally in good agreement with 
the individual secondary chemical shifts, especially the  Cα 
and  Hα values, while C’ and  Cβ provide a less clear correla-
tion. The only exception is helix 9 where some values for 
 Hα deviate somewhat. Even more intriguing is the result 
of the Dangle analysis. We can see an excellent agreement 
of the values with those from the crystal structure. Most 
importantly, the sharp changes of phi and psi between the 
helices are precisely matched for most residues. (Note the 
apparently huge difference in psi prior to the first helix of 
each AR (H1, H3, H5, H7, H9), which is actually very small 
due to the circular periodicity of the dihedral value; i.e., a 
value of + 175° is actually very close to − 175°.) The only 
deviations are seen prior to helix 3, near to H531 and at the 
C-terminus. The region around the former folds in an unu-
sual way and involves rare interactions which cause unusual 
chemical shifts as outlined above. At the latter, the confor-
mation is less well defined and likely to differ between solu-
tion and crystal. We can therefore conclude that for a protein 
with a low level of conformational dynamics, and thus a very 
narrow distribution of conformations in solution and in the 
crystal, we can extract very precise backbone dihedral angle 
constraints.
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